Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)
Ophthalmology
Prevalence
2000.0 / 100K
Incidence
200.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)?
There are 1 clinical trial targeting Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD) tracked by BioSniper.
What is the prevalence of Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)?
The estimated prevalence of Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD) is approximately 2000.0 per 100,000 population.
Deep-dive into Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis